دورية أكاديمية
أعرض في EDS

Exercise vs metformin for gestational diabetes mellitus: Protocol for a network meta-analysis.

التفاصيل البيبلوغرافية
العنوان: Exercise vs metformin for gestational diabetes mellitus: Protocol for a network meta-analysis.
المؤلفون: Pascual-Morena C; Universidad de Castilla - La Mancha, Health and Social Research Center, Cuenca, Spain., Martínez-Vizcaíno V; Universidad de Castilla - La Mancha, Health and Social Research Center, Cuenca, Spain.; Universidad Autónoma de Chile, Facultad de Ciencias de la Salud, Talca, Chile., Álvarez-Bueno C; Universidad de Castilla - La Mancha, Health and Social Research Center, Cuenca, Spain., Pozuelo-Carrascosa DP; Universidad de Castilla - La Mancha, Health and Social Research Center, Cuenca, Spain., Notario-Pacheco B; Universidad de Castilla - La Mancha, Health and Social Research Center, Cuenca, Spain., Saz-Lara A; Universidad de Castilla - La Mancha, Health and Social Research Center, Cuenca, Spain., Fernández-Rodriguez R; Universidad de Castilla - La Mancha, Health and Social Research Center, Cuenca, Spain., Cavero-Redondo I; Universidad de Castilla - La Mancha, Health and Social Research Center, Cuenca, Spain.
المصدر: Medicine [Medicine (Baltimore)] 2019 Jun; Vol. 98 (25), pp. e16038.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
مواضيع طبية MeSH: Exercise* , Meta-Analysis as Topic* , Systematic Reviews as Topic*, Diabetes, Gestational/*therapy , Hypoglycemic Agents/*therapeutic use , Metformin/*therapeutic use, Female ; Fetal Macrosomia ; Humans ; Network Meta-Analysis ; Pregnancy ; Pregnancy Outcome ; Prenatal Care
مستخلص: Introduction: The purpose of this protocol is to provide a network meta-analysis methodology that compares the effects of metformin and physical exercise in the prevention and treatment of gestational diabetes mellitus (GDM) and its associated fetal and maternal morbidity.
Methods and Analysis: This protocol conforms to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) and the recommendations of the Cochrane Collaboration Handbook. An electronic search will be conducted in MEDLINE, EMBASE, Web of Science and the Cochrane Library, from the inception until July 2019. There will be no language restrictions. The Cochrane Collaboration tool for assessing risk of bias (RoB2) and the quality assessment tool for quantitative studies will be used. The Grading of Recommendations, Assessment, Development and Evaluation scale will be used to evaluate the strength of the evidence. A Bayesian network meta-analysis will be carried out, which allows direct and indirect comparison of the interventions, for the risk of GDM, prematurity, caesarean section, macrosomia, hypertensive disorders, insulin requirement, and differences in basal glucose, maternal weight, and weight of the newborn.
Discussion: With this protocol, a methodology is established that resolves the limitations of previous meta-analysis. It will be possible to determine the difference of effect between physical exercise and metformin in the main outcomes of the GDM, as well as the type and intensity of the exercise, and the dose of metformin, more effective.
Ethics and Dissemination: The data included in the network meta-analysis will be obtained from trials that meet accepted ethical standards and the Declaration of Helsinki. The results will be published in a peer-reviewed journal. The evidence obtained could be included in the guidelines of clinical practice in pregnancy.
Strengths and Limitations: A comprehensive methodology is established for the analysis, through network meta-analysis, of the comparative efficacy of metformin and physical exercise in gestational diabetes mellitus. The results obtained could help medical professionals by establishing the best evidence-based interventions which may be recommended for these population groups.
Registration Number: PROSPERO CRD42019121715.
References: Control Clin Trials. 1986 Sep;7(3):177-88. (PMID: 3802833)
J Eval Clin Pract. 2012 Feb;18(1):12-8. (PMID: 20698919)
BMJ. 2013 May 14;346:f2914. (PMID: 23674332)
BMJ. 2015 Jan 02;350:g7647. (PMID: 25555855)
BMJ. 2011 Aug 08;343:d2090. (PMID: 21824904)
BJOG. 2015 Aug;122(9):1167-74. (PMID: 26036300)
BMJ. 2015 Jan 21;350:h102. (PMID: 25609400)
Med Clin (Barc). 2016 Sep 16;147(6):262-6. (PMID: 27040178)
Prog Mol Biol Transl Sci. 2015;135:17-37. (PMID: 26477909)
Diabet Med. 1998 Jul;15(7):539-53. (PMID: 9686693)
Clin Sports Med. 2017 Oct;36(4):741-752. (PMID: 28886825)
Diabetes Care. 2003 Jan;26 Suppl 1:S103-5. (PMID: 12502631)
Diabetes Metab Res Rev. 2018 Jul;34(5):e2999. (PMID: 29488311)
Diabetes Res Clin Pract. 2017 Jul;129:173-181. (PMID: 28531829)
Med Decis Making. 2013 Jul;33(5):607-17. (PMID: 23104435)
J Clin Epidemiol. 1997 Jun;50(6):683-91. (PMID: 9250266)
Curr Diab Rep. 2016 Jan;16(1):7. (PMID: 26742932)
Cell Biochem Biophys. 2015 Mar;71(2):689-94. (PMID: 25269773)
J Endocrinol Invest. 2017 Sep;40(9):899-909. (PMID: 28283913)
Best Pract Res Clin Obstet Gynaecol. 2015 Apr;29(3):339-49. (PMID: 25457858)
Rev Med Chil. 2014 May;142(5):630-5. (PMID: 25427021)
المشرفين على المادة: 0 (Hypoglycemic Agents)
9100L32L2N (Metformin)
تواريخ الأحداث: Date Created: 20190625 Date Completed: 20190703 Latest Revision: 20221005
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC6636956
DOI: 10.1097/MD.0000000000016038
PMID: 31232936
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-5964
DOI:10.1097/MD.0000000000016038